QTNTQ — Quotient Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.16m
- $252.30m
- $38.51m
Annual income statement for Quotient, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2018 March 31st | R2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K/A | 10-K/A | 10-K/A | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 24.7 | 29.1 | 32.7 | 43.4 | 38.5 |
Cost of Revenue | |||||
Gross Profit | 14.3 | 11.9 | 14.9 | 23.3 | 14.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 94.7 | 108 | 113 | 126 | 143 |
Operating Profit | -70 | -79.2 | -80.4 | -82.7 | -105 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -83 | -106 | -105 | -110 | -124 |
Provision for Income Taxes | |||||
Net Income After Taxes | -82.3 | -106 | -105 | -111 | -125 |
Net Income Before Extraordinary Items | |||||
Net Income | -82.3 | -106 | -105 | -111 | -125 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -82.3 | -106 | -105 | -111 | -125 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -80.6 | -77.6 | -58.7 | -47.8 | -48.9 |